Igor Stukalin
Impact in
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- Inflammatory Biomarkers in Disease Prognosis
-
- Renal cell carcinoma treatment
- Lung Cancer Treatments and Mutations
Papers in
- Oncology 20
- Cancer Immunotherapy and Biomarkers 14
- Cutaneous Melanoma Detection and Management 2
-
- Renal cell carcinoma treatment 13
- Lung Cancer Treatments and Mutations 6
- Co-authors
- Daniel Yick Chin Heng (10 shared papers)Daniel E. Meyers (18 shared papers)Aliyah Pabani (12 shared papers)Don Morris (10 shared papers)Nimira Alimohamed (2 shared papers)Daniel Y.C. Heng (11 shared papers)Vishal Navani (8 shared papers)Tina Cheng (7 shared papers)
- Journals
- Journal of Clinical Oncology (8 papers)JAMA Network Open (3 papers)Clinical Genitourinary Cancer (2 papers)Annals of Oncology (2 papers)European Urology (1 paper)
- Partner nations
- CanadaUnited StatesDenmark
In The Last Decade
Igor Stukalin
44 papers receiving 575 citations
Igor Stukalin's Hit Papers
Peers
Comparison fields: 5 of 62
- Oncology 240
- Pulmonary and Respiratory Medicine 199
- Cancer Research 54
- Hepatology 21
- Health Informatics 3
Countries citing papers authored by Igor Stukalin
This map shows the geographic impact of Igor Stukalin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Igor Stukalin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Igor Stukalin more than expected).
Fields of papers citing papers by Igor Stukalin
This network shows the impact of papers produced by Igor Stukalin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Igor Stukalin. The network helps show where Igor Stukalin may publish in the future.
Co-authors
The 25 scholars most cited alongside Igor Stukalin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 47 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Immune-Related Adverse Events and Survival Among Patients With Metastatic NSCLC Treated With Immune Checkpoint Inhibitors Hit paper breakdown → | 2024 | 71 |
| 2 | 2016 | 58 | |
| 3 | 2019 | 57 | |
| 4 | 2022 | 47 | |
| 5 | 2021 | 39 | |
| 6 | 2016 | 36 | |
| 7 | 2021 | 33 | |
| 8 | 2016 | 29 | |
| 9 | 2021 | 23 | |
| 10 | 2019 | 22 | |
| 11 | 2023 | 16 | |
| 12 | 2021 | 14 | |
| 13 | 2023 | 11 | |
| 14 | 2021 | 11 | |
| 15 | 2018 | 11 | |
| 16 | 2020 | 10 | |
| 17 | 2022 | 9 | |
| 18 | 2024 | 8 | |
| 19 | 2020 | 7 | |
| 20 | 2018 | 7 |
About Igor Stukalin
Igor Stukalin is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Surgery and Economics and Econometrics, having authored 47 papers that have together received 578 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (14 papers), Renal cell carcinoma treatment (13 papers), Cancer Genomics and Diagnostics (6 papers), Lung Cancer Treatments and Mutations (6 papers), Economic and Financial Impacts of Cancer (3 papers), Testicular diseases and treatments (3 papers), Cutaneous Melanoma Detection and Management (2 papers) and Renal and related cancers (2 papers). The work is most often cited by research in Oncology (240 citations), Pulmonary and Respiratory Medicine (199 citations), Cancer Research (54 citations), Hepatology (21 citations) and Health Informatics (3 citations). Igor Stukalin has collaborated with scholars based in Canada, United States and Denmark. Frequent co-authors include Daniel Yick Chin Heng, Daniel E. Meyers, Aliyah Pabani, Don Morris, Nimira Alimohamed, Daniel Y.C. Heng, Vishal Navani, Tina Cheng, Siddhartha Goutam and Michelle L. Dean. Their work appears in journals such as Journal of Clinical Oncology, JAMA Network Open, Clinical Genitourinary Cancer, Annals of Oncology and European Urology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.